Rheumatoid Arthritis Drugs Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global rheumatoid arthritis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market include a rise in prevalence of rheumatoid arthritis, expiration of patents & the entry of biosimilar drugs, the surge in geriatric population, increase in adoption of conventional DMARDs, and government initiatives toward spread in awareness for rheumatoid arthritis symptoms. Moreover, innovations in advanced biologics are further anticipated to fuel the growth of the market. Furthermore, a rise in focus associated with early screening and treatment of rheumatoid arthritis is expected to offer high growth potential for the market during the forecast period.
To Request a Sample of our Report on Rheumatoid
Arthritis Drugs Market: https://www.omrglobal.com/request-sample/rheumatoid-arthritis-drugs-market
Rheumatoid arthritis is a
disorder that causes pain and inflammation in joints. It affects individuals of
all ages; however, the geriatric population is highly at risk of affected with
this disease. The symptoms of rheumatoid arthritis consist of pain, stiffness,
tenderness, and swelling of joints. Currently, no cure is available for
rheumatoid arthritis. However, certain drugs are used to efficaciously control
the conditions of rheumatoid arthritis, which include disease-modifying
anti-rheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs),
corticosteroids, and uric acid drugs. According to the Lancet Rheumatology
2020, patients with rheumatoid arthritis who develop COVID-19 infection may be
at high risk for developing severe symptoms and additional complications. Some
DMARDs that are commonly used to treat rheumatoid arthritis, such as
hydroxychloroquine drug, are being investigated as potential therapy for
COVID-19. Moreover, other generally used therapies such as biologics targeting
interleukin (IL)-6 (sarilumab, tocilizumab) and IL-1 (anakinra) are being
assessed in patients with COVID-19. Thus, COVID-19 infection uplifted growth
opportunities for manufacturers of rheumatoid arthritis drugs.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
• Segment
Covered-
Ø
By Drug Type
·
By Distribution Channel
·
By Application
• Regions
covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape: AbbVie Inc., Amgen
Inc., and Bristol-Myers Squibb Company, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Rheumatoid Arthritis Drugs Market is Available @ https://www.omrglobal.com/industry-reports/rheumatoid-arthritis-drugs-market
Global Rheumatoid Arthritis Drugs Market Report by Segment
By Drug Type
·
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
·
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
·
Corticosteroids
·
Biologic Response Modifiers (Biologics)
By Distribution Channel
·
Hard Shelled Capsules
·
Soft Shelled Capsules
By Application
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
Global Rheumatoid Arthritis Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment